Form 6-K GLAXOSMITHKLINE PLC For: Jul 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
GlaxoSmithKline (GSK) Tops Q2 EPS Views
July 29, 2015 7:01 AM EDTGlaxoSmithKline (NYSE: GSK) reported Q2 EPS of 17.3 pence, compared with the analyst estimate of 16.7 pence. Revenue for the quarter came in at £5.89 billion versus the consensus estimate of £5.87 billion.
Sir Andrew Witty, Chief Executive Officer, GSK said:
This is our first full quarter of performance since completion of the transaction... More
